Search results
Results from the WOW.Com Content Network
Shares of vaccine stocks Moderna (NASDAQ: MRNA), Novavax (NASDAQ: NVAX), and BioNTech SE (NASDAQ: BNTX) rallied this week, appreciating 23.4%, 16.4%, and 9.3%, respectively, through Thursday ...
Novavax successfully developed a COVID-19 vaccine that is currently its only product on the market. The company has been working on two other candidates. One is an investigational influenza vaccine.
Over the past year, Pfizer stock has dipped 11%, and Moderna stock has plunged 46%. ... thanks largely to its Comirnaty Covid-19 vaccine and Paxlovid antiviral pill – the boom subsided by early ...
Stocks of coronavirus vaccine could run out at the end of January unless new ones such as the Oxford jab are approved, a former minister has warned. Former health secretary Jeremy Hunt told the ...
The news got even better last week, when the UK drug regulatory commission MHRA authorized Pfizer and BioNTech to distribute their Covid-19 mRNA vaccine for emergency use and the first doses could ...
Vaccine stocks have struggled since RFK Jr.'s appointment to health secretary, with Moderna and Pfizer seeing the deepest losses. Health stocks are tumbling after Trump's appointment of vaccine ...
The gold markets got absolutely crushed as Pfizer has announced that they have a vaccine with a 90% efficacy rating against coronavirus.
A COVID-19 vaccine likely to benefit the Dow the most as it is more inclined toward cyclical stocks. Five among these are NIKE (NKE), Dow (DOW), The Procter & Gamble (PG), 3M (MMM) and Microsoft ...